Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,350
Total Claims
$3.5M
Drug Cost
568
Beneficiaries
$6,136
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-98%
Opioid rate vs peers
0.1% vs 3.8% avg
+422%
Cost per patient vs peers
$6,136 vs $1,174 avg
+195%
Brand preference vs peers
26.2% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$118
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,014 claims · $3.2M
Generic: 14,146 claims · $329K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Epolamine | 821 | $592K |
| Lipase/Protease/Amylase | 428 | $412K |
| Icosapent Ethyl | 1,067 | $409K |
| Cyclosporine | 400 | $306K |
| Mirabegron | 422 | $218K |
| Denosumab | 124 | $214K |
| Dulaglutide | 112 | $132K |
| Empagliflozin | 131 | $95K |
| Lipase/Protease/Amylase | 74 | $88K |
| Sitagliptin Phosphate | 114 | $78K |
| Icosapent Ethyl | 234 | $63K |
| Vortioxetine Hydrobromide | 105 | $57K |
| Semaglutide | 42 | $46K |
| Sitagliptin Phos/Metformin Hcl | 66 | $38K |
| Apixaban | 53 | $32K |
Prescribing Profile
Patient Profile
75
Avg Age
61%
Female
1.11
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data